0. DOCID:28513 SCORE: 0.00465299325011277
DOCNO: 12585984
AUTHOR: Marsha Wittink M
AUTHOR: Joseph B Straton JB
AFFILIATION: Department of Family Practice and Community Medicine, University of Pennsylvania, Philadelphia, USA.
PUBTYPE: Comment
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of family practice.
COUNTRY: United States
TITLE: Self-examination does not reduce breast cancer mortality.
PUBDATE: 20030201
Breast self-examination does not decrease breast cancer mortality, according to the results of this randomized controlled trial of 266,000 women who were given intensive instruction in breast self-examination. These findings correspond with the US Preventive Services Task Force policy not to recommend breast self-examination for the reduction of breast cancer mortality.


1. DOCID:26616 SCORE: 0.00384287024713037
DOCNO: 9858290
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnostic use
QUALIFIER: radionuclide imaging
QUALIFIER: diagnostic use
QUALIFIER: diagnostic use
QUALIFIER: methods
QUALIFIER: methods
AUTHOR: R Burt R
AFFILIATION: Department of Radiology, VAMC and Indiana University, Indianapolis 46202, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Clinical nuclear medicine.
COUNTRY: UNITED STATES
TITLE: Dual isotope F-18 FDG and Tc-99m RBC imaging for lung cancer.
PUBDATE: 19981201
PURPOSE: To produce fluorodeoxyglucose (FDG) images with markers for normal organs and large blood vessels in patients with suspected lung cancer. METHODS: Dual isotope SPECT images were made using F-18 FDG- and Tc-99m-labeled autologous red cells. RESULTS: FDG-positive lesions are localized in relation to major structures when they are viewed in a fused rotating three-dimensional display or in cross sections. CONCLUSIONS: Tc-99m red cell and FDG fusion imaging provides relative location information for lung tumors.


2. DOCID:25770 SCORE: 0.00376960591400527
DOCNO: 9922817
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Extracorporeal Membrane Oxygenation
DESCRIPTOR: Pneumonectomy
DESCRIPTOR: Postoperative Complications
QUALIFIER: surgery
QUALIFIER: surgery
QUALIFIER: therapy
AUTHOR: H Verhelst H
AUTHOR: J Vranken J
AUTHOR: F Muysoms F
AUTHOR: L Rondelez L
AUTHOR: H Schroë H
AUTHOR: R De Jongh R
AFFILIATION: Department of Thoracovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Acta chirurgica Belgica.
COUNTRY: BELGIUM
TITLE: The use of extracorporeal membrane oxygenation in postpneumonectomy pulmonary oedema.
PUBDATE: 19981201
A 59-year-old male developed a severe adult respiratory distress syndrome following a right pneumonectomy for pulmonary cancer. Extracorporeal membrane oxygenation for 11 days was life-saving. The operation was considered curative, but the patient died nine months later with multiple metastases. The pathogenesis and treatment for postpneumonectomy pulmonary oedema and an explanation for rapid dissemination of the cancer are stated.


3. DOCID:26246 SCORE: 0.00365047209715153
DOCNO: 10575902
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Isoflavones
QUALIFIER: prevention & control
QUALIFIER: administration & dosage
QUALIFIER: prevention & control
AUTHOR: L M Chiechi LM
AUTHOR: A Lobascio A
AUTHOR: A Grillo A
AUTHOR: T Valerio T
AFFILIATION: Clinica Ostetrica e Ginecologica III, Università degli Studi, Bari. m.chiechi@pangeanet.it
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Minerva ginecologica.
COUNTRY: ITALY
TITLE: [Phytoestrogen-containing food and prevention of postmenopausal osteoporosis and cardiovascular diseases]
PUBDATE: 19990901
Food phytestrogens and prevention of postmenopausal osteoporotic and cardiovascular disease. Phytestrogens are diphenolic compounds, widely found in plants and foods, with structural and biological estrogen-like similarities. Their anti-estrogenic effects are well known and studied due to the possibility to prevent some tumors such as breast and prostate cancer. In menopause they have an estrogenic-like action on lipidic and bone metabolism. Phytestrogens rich foods can positively affect the postmenopausal osteoporotic and cardiovascular pathology.


4. DOCID:30789 SCORE: 0.0032653666040861
DOCNO: 16350845
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: pharmacology
QUALIFIER: chemistry
AUTHOR: Hyang Rim Kim HR
AUTHOR: Hye-Young Min HY
AUTHOR: Yeon Hee Jeong YH
AUTHOR: Sang Kook Lee SK
AUTHOR: Nam Sook Lee NS
AUTHOR: Eun-Kyoung Seo EK
AFFILIATION: College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea.
PUBTYPE: Journal Article
JOURNALTITLE: Archives of pharmacal research.
COUNTRY: Korea (South)
TITLE: Cytotoxic constituents from the whole plant of Corydalis pallida.
PUBDATE: 20051101
Here we report the cytotoxic activity of three known compounds isolated for the first time from Corydalis pallida (Papaveraceae). An isoquinoline alkaloid, berberine, exhibited cytototoxic activity against two human cancer cell lines, HT-1080 (human fibrosarcoma) and SNU-638 (human stomach adenocarcinoma), with IC50 values of 3.2 and 3.4 microg/mL, respectively. N-trans-feruloyltyramine and N-trans-feruloylmethoxytyramine were also isolated from this plant but were inactive.


5. DOCID:30776 SCORE: 0.00326536413617407
DOCNO: 12073635
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: diagnostic use
QUALIFIER: diagnosis
QUALIFIER: diagnosis
AUTHOR: Takashi Ohata T
AUTHOR: Yoshinao Abe Y
AUTHOR: Tomisato Miura T
AUTHOR: Tatsusuke Sato T
AFFILIATION: Department of Radiology, Hirosaki University School of Medicine.
PUBTYPE: Journal Article
JOURNALTITLE: Nihon Igaku Hōshasen Gakkai zasshi. Nippon acta radiologica.
COUNTRY: Japan
TITLE: [An experimental study for tumor detection by indocyanine green with near-infrared topography]
PUBDATE: 20020501
We studied tumor detection by indocyanine green (ICG) with near-infrared topography in rat experimental tumors: hepatoma AH109A and osteosarcoma POB 102. Time-intensity curves and topograms after ICG injection were obtained in tumors and surrounding normal tissues. Intensities in tumors were slowly reduced, and intensities in normal tissues were rapidly reduced, resulting in positive tumor image in topogram. It is concluded that near-infrared topography enhanced by ICG is useful for cancer detection.


6. DOCID:30344 SCORE: 0.00326530530193654
DOCNO: 16194717
OWNER: NLM
STATUS: In-Data-Review
QUALIFIER: surgery
AUTHOR: W Scott McDougal WS
AFFILIATION: Department of Urology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. wmcdougal@partners.org
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Urology.
COUNTRY: United States
TITLE: Advances in the treatment of carcinoma of the penis.
PUBDATE: 20051101
The aim of this article is to define the therapeutic advances in the treatment of penile cancer over the past 2 decades. A literature search was conducted for articles in which a major change in therapy was documented as beneficial. Case records were then reviewed in patients who underwent such procedures. Major advances have involved less disfiguring treatment of the primary lesion in selected cases and the recognition of improved survival by altering the timing of groin dissection for those at risk for metastatic disease.


7. DOCID:31827 SCORE: 0.00311115108557721
DOCNO: 12110209
AUTHOR: Robin A Weiss RA
AFFILIATION: Department of Immunology and Molecular Pathology, University College London, 46 Cleveland Street, London W1T 4JF, UK. r.weiss@ucl.ac.uk
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Trends in microbiology.
COUNTRY: England
TITLE: Virulence and pathogenesis.
PUBDATE: 20020701
Why do viruses cause disease? As intracellular parasites they grow at the expense of the host, yet many infections are non-virulent. We tend to focus on unusual outcomes of infection that are important to the individual but trivial for host-parasite evolution, for example, paralytic polio or viral cancer. The assumption that the features of disease help onward transmission of the virus is true for, say, rabies, but not for AIDS or neurodegenerative diseases. Moreover, minor host differences can result in major changes in pathogen virulence. Although viral burden relates to disease severity, pathogenesis is not necessarily coupled with transmission dynamics.


8. DOCID:29703 SCORE: 0.0030701440173753
DOCNO: 15611792
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: epidemiology
QUALIFIER: epidemiology
QUALIFIER: complications
AUTHOR: S K Maitra SK
AUTHOR: H Gallo H
AUTHOR: C Rowland-Payne C
AUTHOR: D Robinson D
AUTHOR: H Møller H
AFFILIATION: Thames Cancer Registry, Division of Cancer Studies, Guy's, King's and St Thomas' School of Medicine, Capital House, 42 Weston Street, London SE1 3QD, UK. sombith.maitra@kcl.ac.uk
PUBTYPE: Journal Article
JOURNALTITLE: British journal of cancer.
COUNTRY: England
TITLE: Second primary cancers in patients with squamous cell carcinoma of the skin.
PUBDATE: 20050201
The occurrence of second primary cancers was explored in patients with squamous cell cancer of the skin (SCC). The excess incidence subsequent to SCC was mainly in cancers related to sunlight and smoking, and in lymphoproliferative malignancies, it was largest (10-fold) in salivary gland cancer.


9. DOCID:30035 SCORE: 0.00306789185264436
DOCNO: 16382715
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Mass Screening
QUALIFIER: statistics & numerical data
QUALIFIER: analysis
QUALIFIER: diagnosis
AUTHOR: Valentin Praz V
AUTHOR: Patrice Jichlinski P
AUTHOR: Danièla Aymon D
AUTHOR: Hans-Jürg Leisinger HJ
AFFILIATION: Service d'urologie, CHUV, 1011 Lausanne. Valentin.Praz@chuv.ch
PUBTYPE: Journal Article
JOURNALTITLE: Revue médicale suisse.
COUNTRY: Switzerland
TITLE: [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud]
PUBDATE: 20051201
This investigation brings information on the practice of 300 general practitioners of the canton of Vaud as for the use of the prostate-specific antigen (PSA) and the digital rectal examination (DRE) in the prostate cancer screening. The high rate of answer shows their interest for this problem which they deal with in adequacy with the international recommendations published by the societies of urology.


10. DOCID:29855 SCORE: 0.00306788964776433
DOCNO: 16299540
OWNER: NLM
STATUS: In-Data-Review
DESCRIPTOR: Oncolytic Virotherapy
QUALIFIER: virology
QUALIFIER: pathogenicity
AUTHOR: Frank McCormick F
AFFILIATION: University of California San Francisco, Cancer Research Institute, CA 94115, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Oncogene.
COUNTRY: England
TITLE: Future prospects for oncolytic therapy.
PUBDATE: 20051101
Viruses have been engineered to replicate selectively in cancer cells, based on a number of innovative principles. Several of these viruses have entered clinical trials and have proven relatively safe, and have shown evidence of efficacy. However, further research is required to enable these agents to function systemically. This might involve attempts to suppress immune responses to virus antigens, and re-targeting of viruses to favor tumor infection and increased potency. When these barriers are overcome, oncolytic viruses could enter the mainstream of clinical oncology.


11. DOCID:25968 SCORE: 0.00303124272249125
DOCNO: 10966154
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pharmacology
QUALIFIER: analogs & derivatives
QUALIFIER: pharmacology
AUTHOR: S Suzen S
AUTHOR: E Buyukbingol E
AFFILIATION: Department of Pharmaceutical Chemistry, Faculty of Pharmacy (ECZACILIK), Ankara University, Turkey. sibel@pharmacy.ankara.edu.tr
PUBTYPE: Journal Article
JOURNALTITLE: Farmaco (Società chimica italiana : 1989)
COUNTRY: ITALY
TITLE: Anti-cancer activity studies of indolalthiohydantoin (PIT) on certain cancer cell lines.
PUBDATE: 20000401
5-(2-Phenyl-3'-indolal)-2-thiohydantoin (PIT) has been evaluated as an anti-cancer compound on several cancer lines organised in to subpanels representing leukemia, melanoma, and cancer of lung, colon, kidney, ovary, breast, prostate and central nervous system by the National Cancer Institute (NCI) anti-cancer drug screen programme. The compound showed inhibitory activity on several cancer cell lines. No information is available on anti-cancer potency of this compound with normal cell lines.


12. DOCID:31920 SCORE: 0.00301788167828139
DOCNO: 12806939
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: adverse effects
AUTHOR: Toshio Shimizu T
AUTHOR: Nagahiro Saijo N
AFFILIATION: Department of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Nippon rinsho. Japanese journal of clinical medicine.
COUNTRY: Japan
TITLE: [Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment]
PUBDATE: 20030601
In 1998, the National Cancer Institute (NCI) made an effort to revise and expand the Common Toxicity Criteria (CTC) in cancer treatment. New CTC version 2.0 includes more than 279 individual adverse events with more than 24 of these applicable to adverse reaction category. The Radiation Therapy Oncology Group(RTOG) Acute Radiation Morbidity Scoring Criteria and BMT Complex/Multi-Component Events were added to New CTC version 2.0. CTC version 2.0 represents an improvement in the evaluation and grading of toxicity for all modalities in cancer treatment.


13. DOCID:28907 SCORE: 0.00294571520294537
DOCNO: 12670043
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: chemistry
QUALIFIER: antagonists & inhibitors
QUALIFIER: chemistry
AUTHOR: Toshiya Mori T
AUTHOR: Kazuo Shin-ya K
AUTHOR: Kosuke Takatori K
AUTHOR: Maki Aihara M
AUTHOR: Yoichi Hayakawa Y
AFFILIATION: Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of antibiotics.
COUNTRY: Japan
TITLE: Byssochlamysol, a new antitumor steroid against IGF-1-dependent cells from Byssochlamys nivea. II. Physico-chemical properties and structure elucidation.
PUBDATE: 20030101
The structure of byssochlamysol, a new antitumor metabolite against IGF-1-dependent cancer cells from Byssochlamys nivea M#5187, was determined to be a highly oxidized ergostane steroid as shown in Fig. 1 by NMR studies.


14. DOCID:27933 SCORE: 0.00294121590334278
DOCNO: 10652481
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Gene Therapy
QUALIFIER: genetics
QUALIFIER: therapy
AUTHOR: G A Chung-Faye GA
AUTHOR: D J Kerr DJ
AUTHOR: L S Young LS
AUTHOR: P F Searle PF
AFFILIATION: CRC Institute of Cancer Studies, University of Birmingham, Birmingham, UK B15 2TA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Molecular medicine today.
COUNTRY: ENGLAND
TITLE: Gene therapy strategies for colon cancer.
PUBDATE: 20000201
Colorectal cancer is the second most common cause of cancer mortality in Western countries. Gene therapy represents a novel approach to the treatment of colorectal cancer, and this review addresses the current strategies and ongoing clinical trials, including gene correction, immunomodulatory approaches and virus-directed enzyme-prodrug systems. Although the pre-clinical results for these strategies have been encouraging, clinical trials have not yet reflected these data. However, gene therapy for colorectal cancer is still in the early stages of development, and its potential, particularly in combination with conventional cancer therapies, warrants further investigation.